Navigation Links
Stereotaxis' Board of Directors Reaffirms Commercialization Plans for Epoch™ and Odyssey™ Product Platforms
Date:8/30/2011

ST. LOUIS, Aug. 30, 2011 /PRNewswire/ -- The Board of Directors of Stereotaxis, Inc. (NASDAQ: STXS) announced today following its regularly scheduled board meeting that it reaffirmed the Company's plans for both the launch of the Epoch platform and expansion of the Odyssey  platform into standard labs.

"At our meeting last week, the Board reviewed and endorsed the commercial strategies put forth for the launch of Epoch, as well as for the expansion of Odyssey's market penetration into standard labs," said Fred A. Middleton, Chairman of the Board of Directors.  "We are encouraged by the positive early physician feedback to Epoch's productivity enhancements, and remain optimistic about the commercial potential for the Epoch magnetic surgery platform for robotic assisted surgeries in the cardiology suite.  We are also encouraged by the positive trends in recurring revenue as reflected in our financial statements."

Mr. Middleton added, "The Board has established a Strategy Committee to evaluate various capital raising strategies to fund the Company's planned growth initiatives over the next 18 months, and we are focused on non-equity sources of funding as our first choice for raising capital since we believe our common stock is significantly undervalued in the public market."

The Company also completed last week its previously announced plans for operating expense reductions amounting to approximately 15 to 20% of annual operating expenses.

About Stereotaxis             www.stereotaxis.com         www.odysseyexperience.com

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Stereotaxis to Present at the Stifel Nicolaus Healthcare Conference on September 7, 2011
2. Stereotaxis to Present at the Canaccord Genuity Growth Conference on August 11, 2011
3. Stereotaxis Reports Second Quarter Financial Results; Rebalances Investment Around Commercialization of Epoch™ and Odyssey™
4. Stereotaxis to Report Second Quarter 2011 Financial Results and Conduct Conference Call on August 8, 2011
5. Stereotaxis and Biosense Webster Announce New Strategic Collaboration
6. Stereotaxis Continued Leadership in Scientific Outcome Data Prominently Displayed with Multiple Key Presentations at HRS 2011
7. Stereotaxis Reports First Quarter 2011 Financial Results
8. Stereotaxis Introduces New Electrophysiology Platform: Epoch™
9. Stereotaxis to Present at Upcoming Investor Conferences
10. Stereotaxis Reports 2010 Financial Results, Provides 2011 Financial Outlook
11. Stereotaxis Announces First Worldwide Use of Remote Magnetic Navigation for Renal Ablation to Treat Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 1, 2014  SI-BONE, Inc., a medical device company that ... a minimally invasive surgical (MIS) device indicated for fusion for ... expansion of its European operations with the formation of a ... as General Manager, Germany.  Mr. Schaber will join former Kyphon ... Europe , Middle East ...
(Date:10/1/2014)...  CVS Health is thanking its 26,000 pharmacists during ... the way health care is delivered to increase access, ... pharmacies, mail service pharmacies and specialty pharmacies nationwide.  ... to CVS Health to reflect our broader health care ... to shape the future of health," said Larry ...
(Date:10/1/2014)... Switzerland , October 1, 2014 /PRNewswire/ ... Clinical Genomics and Next Generation Sequencing (NGS) data analysis, ... to run full cystic fibrosis analysis in a single ... and characterisation of all types of variants in a ... Until now, it has not been possible to ...
Breaking Medicine Technology:SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 2SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 3SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 4CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 2CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 3Sophia Genetics Launches Full CFTR Analysis in Single Clinical Grade NGS Experiment 2
... 2011 Reportlinker.com announces that a new market ... The Outlook for Medical Devices in ... http://www.reportlinker.com/p0559145/The-Outlook-for-Medical-Devices-in- Brazil-Russia-India--China.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Managed_care 4 Key Markets ... BRAZIL: Medical Market Size US$3.6 ...
... announces that a new market research report is available in ... in Central & Eastern Europe http://www.reportlinker.com/p0192646/The-Outlook-for-Medical-Devices-in-Central--Eastern-Europe.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Managed_care ... Bulgaria Croatia ... Poland Romania Russia ...
Cached Medicine Technology:The Outlook for Medical Devices in Brazil, Russia, India & China 2The Outlook for Medical Devices in Brazil, Russia, India & China 3The Outlook for Medical Devices in Brazil, Russia, India & China 4The Outlook for Medical Devices in Central & Eastern Europe 2The Outlook for Medical Devices in Central & Eastern Europe 3The Outlook for Medical Devices in Central & Eastern Europe 4The Outlook for Medical Devices in Central & Eastern Europe 5
(Date:10/1/2014)... protein beta-amyloid is strongly associated with Alzheimer,s disease; however, ... peptide is the causal agent of the onset and ... confirmation is that beta-amyloid is not harmful when found ... when it self-assembles to form the so-called amyloid fibrils ... beta-amyloid alone, but with multiple ones because each aggregate ...
(Date:10/1/2014)... new research study published today in the Journal ... patients older than 50 years with moderate or severe ... , Researchers from the University of Melbourne randomly assigned ... pain to no acupuncture or sham or pretend laser ... with participants and acupuncturists blinded to laser and sham ...
(Date:10/1/2014)... Physical Sciences Research Council (EPSRC) will focus on ... systems which run, for example, manufacturing plants, power ... , The research will help understand and ... systems behind our critical national infrastructure. , ... (RITICS), based at Imperial College London, is co-ordinating ...
(Date:10/1/2014)... BOSTON (October 1, 2014) Despite a policy ... with developmental disabilities, this vulnerable population continues to ... of The Journal of the American Dental ... Medicine and Tufts University School of Dental Medicine ... factors influencing at-home oral care provided by caregivers ...
(Date:10/1/2014)... 2014 Familylifeinsurancequotes.org has released a ... for senior citizens. , Senior citizens can qualify ... sell coverage to seniors who are over 50 years ... without taking a medical examination. , Term life insurance ... senior clients can qualify. Having life insurance during retirement ...
Breaking Medicine News(10 mins):Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2Health News:Study finds acupuncture does not improve chronic knee pain 2Health News:£2.5 million to recognize and reduce cyber-attack threats to critical infrastructure 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Affordable Term Life Insurance - Senior Citizens Can Qualify for Coverage! 2
... an Army leader and a military surgeon are among the ... the Henry M. Jackson Foundation for the Advancement of Military ... which will take place at the National Museum of Women ... by service members, veterans and civilians who are working together ...
... News) -- Prenatal diagnosis, early surgery and well-coordinated care by ... cleft lip and/or cleft palate, experts say. Cleft lip ... pregnancy when the roof of the mouth fails to fuse ... United States each year and is the second most common ...
... Tierney, M.D., president and CEO of the Regenstrief Institute ... Indiana University School of Medicine, received a 2011 Distinguished ... and Education Meeting on April 28 in Washington, DC. ... Achievement and Contribution to Clinical and Translational Science. He ...
... A gene known to be important in cardiac development ... result in obstruction of the left ventricular outflow tract. ... Nationwide Children,s Hospital and appearing in the journal ... outflow tract (LVOT) malformations, including aortic valve stenosis, coarctation ...
... Australia and Europe. Large resources are set aside for research ... the research field is still new but researchers from ... years ago the Norwegian health care system had a low ... sectors", says Professor Karina Aase at the University of Stavanger. ...
... in powerful positions are just as likely as men to cheat ... that men are more likely than women to cheat on their ... gender, according to the study published April 28 in the journal ... research in the past that indicates that gender is the strongest ...
Cached Medicine News:Health News:Dinner to honor icons of military medicine 2Health News:Early Surgery Boosts Outcomes for Babies With Cleft Palate 2Health News:Tierney named 2011 Clinical and Translational Research Distinguished Investigator 2Health News:Study identifies second gene associated with specific congenital heart defects 2Health News:Sustaining vulnerable lives 2Health News:Sustaining vulnerable lives 3Health News:Powerful Women as Likely to Cheat as Men, Study Finds 2
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
... infectious disease ELISA products make us a ... protocols for faster integration into the busy ... increased reliability and run-to-run consistency. Our Infectious ... for a wide range of serological assays ...
... infectious disease ELISA products make us a ... protocols for faster integration into the busy ... increased reliability and run-to-run consistency. Our Infectious ... for a wide range of serological assays ...
... We offer a complete line ... laboratorians state-of-the-art monoclonal and monoclonal/polyclonal ... detection of enteric pathogens in ... products for Clostridium difficile, Entamoeba ...
Medicine Products: